G Niebch

930 total citations
31 papers, 776 citations indexed

About

G Niebch is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, G Niebch has authored 31 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Biochemistry and 5 papers in Molecular Biology. Recurrent topics in G Niebch's work include Metabolism and Genetic Disorders (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Alcoholism and Thiamine Deficiency (4 papers). G Niebch is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Alcoholism and Thiamine Deficiency (4 papers). G Niebch collaborates with scholars based in Germany, United Kingdom and United States. G Niebch's co-authors include Róbert Hermann, Edith Schneider, Harald O. Borbe, Henning Blume, T. Schilling, Manfred Heim, Axel‐R. Hanauske, Hermann Dietzfelbinger, Peter Ruus and Mathias Locher and has published in prestigious journals such as Journal of Clinical Oncology, FEBS Letters and Human Reproduction.

In The Last Decade

G Niebch

30 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Niebch Germany 16 220 204 165 138 108 31 776
D. Andrew Stevenson United States 15 214 1.0× 21 0.1× 85 0.5× 131 0.9× 80 0.7× 20 761
Tadayuki Takashima Japan 24 257 1.2× 113 0.6× 42 0.3× 473 3.4× 67 0.6× 39 1.1k
Jens Teichert Germany 16 265 1.2× 315 1.5× 186 1.1× 71 0.5× 28 0.3× 22 823
F.A.J. Muskiet Netherlands 14 314 1.4× 147 0.7× 112 0.7× 97 0.7× 12 0.1× 29 836
Vassiliki Villiotou Greece 16 242 1.1× 67 0.3× 16 0.1× 32 0.2× 34 0.3× 31 882
Jack H. Fellman United States 9 106 0.5× 52 0.3× 196 1.2× 16 0.1× 26 0.2× 16 559
Slobodan Milovanović Serbia 14 169 0.8× 18 0.1× 20 0.1× 136 1.0× 37 0.3× 29 531
Nancy Agrawal United States 20 278 1.3× 82 0.4× 15 0.1× 143 1.0× 99 0.9× 39 1.1k
Hikaru Sakamoto Japan 13 223 1.0× 42 0.2× 179 1.1× 17 0.1× 23 0.2× 36 677
Martha Carlson United States 16 279 1.3× 39 0.2× 93 0.6× 85 0.6× 30 0.3× 30 1.2k

Countries citing papers authored by G Niebch

Since Specialization
Citations

This map shows the geographic impact of G Niebch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Niebch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Niebch more than expected).

Fields of papers citing papers by G Niebch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Niebch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Niebch. The network helps show where G Niebch may publish in the future.

Co-authorship network of co-authors of G Niebch

This figure shows the co-authorship network connecting the top 25 collaborators of G Niebch. A scholar is included among the top collaborators of G Niebch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Niebch. G Niebch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermann, Róbert, Jürgen Borlak, Ullrich Munzel, et al.. (2006). The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. The Pharmacogenomics Journal. 6(3). 211–219. 15 indexed citations
2.
Hermann, Róbert, et al.. (2003). Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects. European Journal of Clinical Pharmacology. 58(12). 795–802. 46 indexed citations
3.
Ludwig, Michael, Carola Albano, F. Olivennes, et al.. (2002). Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide®) in controlled ovarian stimulation for IVF. Archives of Gynecology and Obstetrics. 266(1). 12–17. 14 indexed citations
4.
Breithaupt‐Grögler, Kerstin, G Niebch, Edith Schneider, et al.. (1999). Dose-proportionality of oral thioctic acid — coincidence of assessments via pooled plasma and individual data. European Journal of Pharmaceutical Sciences. 8(1). 57–65. 73 indexed citations
5.
Duijkers, Ingrid, Christine Klipping, Wim N.P. Willemsen, et al.. (1998). Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers. Human Reproduction. 13(9). 2392–2398. 87 indexed citations
6.
Hermann, Róbert, et al.. (1998). Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers. European Journal of Pharmaceutical Sciences. 6(1). 27–37. 15 indexed citations
7.
Niebch, G, et al.. (1997). Enantioselective high-performance liquid chromatography assay of (+)R- and (?)S-?-lipoic acid in human plasma. Chirality. 9(1). 32–36. 31 indexed citations
8.
Schneider, Edith, G Niebch, Róbert Hermann, Peter Ruus, & Harald O. Borbe. (1995). Absolute bioavailability of flupirtine capsules drops and suppositories in man. European Journal of Clinical Pharmacology. 49. 161. 1 indexed citations
9.
Schilling, T., et al.. (1995). Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane. Investigational New Drugs. 13(4). 327–332. 124 indexed citations
10.
Kirsten, R., Matthias Breidert, Amy Heine, et al.. (1994). Naftopidil inhibits 5-hydroxytryptamine-induced platelet aggregation and 5-hydroxytryptamine uptake in platelets of healthy volunteers. European Journal of Clinical Pharmacology. 46(3). 271–4. 3 indexed citations
11.
Kutscher, Bernhard, et al.. (1993). Synthese von potentiellen Naftopidil‐Metaboliten. Archiv der Pharmazie. 326(10). 803–806. 1 indexed citations
12.
Hummel, Thomas, et al.. (1991). Dose‐related analgesic effects of flupirtine.. British Journal of Clinical Pharmacology. 32(1). 69–76. 32 indexed citations
13.
Niebch, G, et al.. (1991). Metabolic fate of the novel antihypertensive drug naftopidil.. PubMed. 41(10). 1027–32. 6 indexed citations
14.
Borbe, Harald O., G Niebch, & B Nickel. (1990). Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat. PubMed. 32. 131–137. 20 indexed citations
15.
Niebch, G, et al.. (1990). High-performance liquid chromatography of naftopidil, a novel antihypertensive drug, and two metabolites in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 534. 247–252. 8 indexed citations
16.
Abrams, S. M. L., L. R. I. Baker, Peter Crome, et al.. (1988). Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment. Postgraduate Medical Journal. 64(751). 361–363. 18 indexed citations
17.
Hedges, A, SJ Warrington, Paul Turner, & G Niebch. (1987). Flupirtine maleate and antipyrine half-life. European Journal of Clinical Pharmacology. 33(4). 437–437. 2 indexed citations
18.
Nickel, B, et al.. (1986). Fenetylline: New results on pharmacology, metabolism and kinetics. Drug and Alcohol Dependence. 17(2-3). 235–257. 19 indexed citations
19.
Niebch, G, et al.. (1985). [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].. PubMed. 35(1). 60–7. 23 indexed citations
20.
Jaeger, H, et al.. (1985). [The bioavailability and pharmacokinetics of two carbocysteine preparations after single and multiple dosing].. PubMed. 35(1). 163–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Andrew Stevenson Breakdown of academic impact, for papers by Tadayuki Takashima Breakdown of academic impact, for papers by Jens Teichert Breakdown of academic impact, for papers by F.A.J. Muskiet Breakdown of academic impact, for papers by Vassiliki Villiotou Breakdown of academic impact, for papers by Jack H. Fellman Breakdown of academic impact, for papers by Slobodan Milovanović Breakdown of academic impact, for papers by Nancy Agrawal Breakdown of academic impact, for papers by Hikaru Sakamoto Breakdown of academic impact, for papers by Martha Carlson
Rankless by CCL
2026